NCT04520945 - Phase 2B Clinical Study of Chondrogen for Treatment of Knee Osteoarthritis | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

October 31, 2020

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2022

Conditions

Osteoarthritis, Knee

Interventions

BIOLOGICAL

Chondrogen

Mesenchymal stem cell-derived from umbilical cord Wharton Jelly and hyaluronic acid

BIOLOGICAL

Placebo

Consist of saline and hyaluronic acid

Trial Locations (1)

56000

Department of Orthopedic & Traumatology, Faculty of Medicine, Hospital Canselor Tuanku Mukhriz, UKM Medical Centre, Jalan Yaacob Latiff, Bandar Tun Razak, Cheras, 56000 Kuala Lumpur., Cheras